1 Min Read
* BIOPHYTIS FILED IND APPLICATION FOR APPROVAL BY FDA OF SARA-INTEREST PHASE 2B STUDY OF SARCONEOS IN SARCOPENIA
* FILING IN EUROPE WILL BE DONE IN THE COMING DAYS Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.